MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are small non-coding RNA regulators of protein synthesis that function as "fine-tuning" tools of gene expression in development and tissue homeostasis. Their profiles are significantly altered in neurodegenerative diseases such as Alzheimer's disease (AD) that is characterized by both amyloid-β (Aβ) and tau deposition in brain. A key challenge remains in determining how changes in miRNA profiles translate into biological function in a physiological and pathological context. The key lies in identifying specific target genes for deregulated miRNAs and understanding which pathogenic factors trigger their deregulation. Here we review the literature about the intricate network of miRNAs surrounding the regulation of the amyloid precursor protein (APP) from which Aβ is derived by proteolytic cleavage. Normal brain function is highly sensitive to any changes in APP metabolism and miRNAs function at several steps to ensure that the correct APP end product is produced and in the right form and abundance. Disruptions in this miRNA regulatory network may therefore alter Aβ production, which in turn can affect miRNA expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992 · cited 2×
“…region at its carboxy-terminus, sAPPβ has been reported to function as a death receptor 6 ligand and to mediate axonal pruning and neuronal cell death (Nikolaev et al., 2009). c99 is subsequently cleaved by the γsecretase complex (that is composed of at least four components; presenilin,…”
RetractedA Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592 · cited 2×
“One approach to circumvent this inherent problem is to over-express or inhibit individual miRNAs and analyze protein levels by using proteomics approaches such as stable-isotope labeling with amino acid in cell culture (SILAC) (Baek et al., 2008, Selbach et al., 2008).”
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 2×
“One approach to circumvent this inherent problem is to over-express or inhibit individual miRNAs and analyze protein levels by using proteomics approaches such as stable-isotope labeling with amino acid in cell culture (SILAC) (Baek et al., 2008, Selbach et al., 2008).”
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214 · cited 1×
“Evolutionary conserved, these 19-24 nucleotide-long non-coding RNAs negatively regulate expression of specific mRNA targets through base pairing between their " seed region " and sequences commonly located in the 3'UTR of their targets (Fabian et al., 2010, Siomi and Siomi, 2010).”
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“More specifically, studies in transgenic animals revealed that for Aβ to exert its toxic effects tau is required (Ittner and Gotz, 2011, Ittner et al., 2010, Roberson et al., 2007).”
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“More specifically, studies in transgenic animals revealed that for Aβ to exert its toxic effects tau is required (Ittner and Gotz, 2011, Ittner et al., 2010, Roberson et al., 2007).”
Self-citationAmyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 1×
“While increased Aβ levels characterize AD pathology, the precise mechanisms and signaling cascades that Aβ uses to exert its toxicity are only partly understood (da Cruz e Silva et al., 2010, Lim et al., 2010, Palop and Mucke, 2010).”
Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St. Laurent III, G., Kenny, P. J., & Wahlestedt, C. (2008) · Nature Medicine · doi:10.1038/nm1784 · Cited by 1,416 · cited 1×
“Finally, in APP mutant Tg19959 mice, BACE1 levels were increased while miR-103 and -107 levels were decreased (Faghihi et al., 2008), however whether there is a direct relationship or not remains to be elucidated.”
Cited by
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
“In the AD brain, miR106b was shown to be downregulated in vivo.(97) In relapsing patients with multiple sclerosis (MS), miR-18 was found to be overexpressed compared with controls.”
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders
Parikshak, N. N., Gandal, M. J., & Geschwind, D. H. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3934 · Cited by 430
“A causal factor, such as genetic variation, that can be used to orient edges to transform an undirected correlational network to a directed causal network. mi RNAs such as miR-339-5p in dementia are in their early stages 155–157 but promise to reveal novel regulators of neurodegeneration.”
BackgroundBurgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094839 · Cited by 385
“Many of the miRNAs we were able to detect as differentially expressed in cell-free CSF and SER have been reported previously in studies examining brain tissue from patients with AD and PD [22,24,26,29,51,52,53,54], or as miRNAs that target genes of particular interest- such as APP, BACE1 and a-synuclein [54,55,56].”
BackgroundMicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., & Miyazawa, T. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130932 · Cited by 256
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., & Jahn, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126423 · Cited by 236
Metadata
- Authors
- Schonrock, N., Matamales, M., Ittner, L. M., & Götz, J.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 235
- Issue
- 2
- Pages
- 447-454
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2036556087
- Cited by
- 93
- References
- 31
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.expneurol.2011.11.013
- The paper
- Schonrock, N., Matamales, M., Ittner, L. M., & Götz, J. (2012). MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2011.11.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.